India's Aurobindo repurchases $6.1 million in 0% convertibles

By Devika Patel

Knoxville, Tenn., March 10 - Aurobindo Pharma Ltd. informed the Singapore Stock Exchange that it bought back and canceled $5 million of its $200 million in tranche A and tranche B zero-coupon convertible bonds due 2011 and $1.1 million of its $60 million in zero-coupon convertible bonds due 2010.

The company bought back $3 million of the tranche A bonds and $2 million of the tranche B bonds.

Aurobindo is a pharmaceutical company located in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.